HRT Financial’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,117
| Closed | -$4.4M | – | 2540 |
|
|
2025
Q1 | $4.4M | Sell |
10,117
-13,076
| -56% | -$5.69M | 0.03% | 398 |
|
|
2024
Q4 | $8.56M | Buy |
23,193
+15,310
| +194% | +$5.65M | 0.04% | 214 |
|
|
2024
Q3 | $4.1M | Buy |
7,883
+7,381
| +1,470% | +$3.84M | 0.02% | 518 |
|
|
2024
Q2 | $272K | Buy |
+502
| New | +$272K | ﹤0.01% | 1387 |
|
|
2024
Q1 | – | Sell |
-10,036
| Closed | -$4.73M | – | 2360 |
|
|
2023
Q4 | $4.73M | Buy |
10,036
+2,080
| +26% | +$981K | 0.03% | 302 |
|
|
2023
Q3 | $3.46M | Sell |
7,956
-49,770
| -86% | -$21.7M | 0.03% | 384 |
|
|
2023
Q2 | $25.6M | Buy |
+57,726
| New | +$25.6M | 0.24% | 49 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2466 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2433 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2797 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2990 |
|
|
2022
Q1 | – | Sell |
-52,159
| Closed | -$24.2M | – | 2992 |
|
|
2021
Q4 | $24.2M | Buy |
+52,159
| New | +$24.2M | 0.14% | 74 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3137 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2890 |
|
|
2021
Q1 | – | Sell |
-34,474
| Closed | -$11.1M | – | 2579 |
|
|
2020
Q4 | $11.1M | Buy |
+34,474
| New | +$11.1M | 0.22% | 73 |
|
|
2020
Q3 | – | Sell |
-3,991
| Closed | -$1.05M | – | 1912 |
|
|
2020
Q2 | $1.05M | Buy |
+3,991
| New | +$1.05M | 0.03% | 473 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 776 |
|
|
2019
Q4 | – | Sell |
-6,929
| Closed | -$1.66M | – | 1216 |
|
|
2019
Q3 | $1.66M | Buy |
+6,929
| New | +$1.66M | 0.08% | 160 |
|
|
2019
Q2 | – | Sell |
-2,142
| Closed | -$614K | – | 771 |
|
|
2019
Q1 | $614K | Buy |
+2,142
| New | +$614K | 0.1% | 135 |
|
|
2018
Q2 | – | Sell |
-6,073
| Closed | -$1.33M | – | 281 |
|
|
2018
Q1 | $1.33M | Buy |
+6,073
| New | +$1.33M | 0.64% | 32 |
|
|
2015
Q3 | – | Sell |
-2,244
| Closed | -$368K | – | 100 |
|
|
2015
Q2 | $368K | Buy |
+2,244
| New | +$368K | 0.17% | 74 |
|